WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the Trump administration's crackdown on pharmaceutical advertising.

What You Need To Know • The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy • The Food and Drug Administration on Tuesday sent letters to Hims & Hers and dozens of other companies, ordering them to halt "false and misleading" statements about their medications • It's the first time regulators have gone after online prescribing services, which don't typically fall under FDA authority • The FDA says

See Full Page